Celldex Therapeutics Inc (NASDAQ:CLDX)

2.42
Delayed Data
As of Feb 21
 +0.05 / +2.11%
Today’s Change
2.20
Today|||52-Week Range
3.94
-14.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues4.1M3.6M5.5M6.8M
 
 
 
 
 
Cost of Goods Sold2.3M0.000.00--
 
 
Depreciation And Amortization2.9M3.4M4.0M4.1M
 
 
 
 
 
 
Operating ExpensesGross Income-1.2M185.0K1.5M--
 
 
 
 
General Expenses80.3M122.6M131.0M130.7M
 
 
 
 
 
Research And Development65.5M102.0M100.2M102.0M
 
 
 
 
 
Total Operating Expenses85.6M126.0M135.0M134.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-81.4M-122.4M-129.5M-128.0M
 
 
 
 
 
Extraordinary Charge0.000.000.00-5.0M
 
 
Interest Expense On Debt927.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-81.6M-118.1M-127.2M-128.5M
 
 
 
 
 
Net Income-81.6M-118.1M-127.2M-128.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS79.8M89.4M97.1M101.5M
 
 
 
 
 
Shares To Calculate EPS Diluted79.8M89.4M97.1M101.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.02-$1.32-$1.31-$1.27
 
 
 
 
 
EPS Diluted-$1.02-$1.32-$1.31-$1.27